Invokamet XR

Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Market Realist
Mon, 09/26/16 - 09:58 am
JNJ
FDA
type 2 diabetes
diabetes
Invokamet XR
Janssen